Biotech moves fast. Your CRO should too.

活動詳細資訊:

If you’ve landed here, you likely spotted one of our Novotech vehicles on the streets of San Francisco. Meet the Novotech team at JPM and learn how we help biotechs move faster, navigate complexity, and scale globally.

What we offer biotechs

We connect the world’s most effective clinical environments into one integrated development pathway. 4,450+ clinical trials delivered 7,260+ sites initiated, partnerships with 4950+ investigators, across 50+ countries worldwide.

Move faster

• Start first-in-human (FIH) in Australia without an IND, using established regulatory pathways and experienced local teams.
• Activate sites quickly in high-performing regions so you can reach decision-making data sooner.

Spend smarter

• Tap capital-efficient regions across APAC and China, where startup, monitoring, and enrollment costs can be lower than in traditional markets.
• Structure studies to balance cost, speed, and quality, ensuring your funds are focused on reaching your next milestone.

Scale globally

• Integrate North America, Europe, and APAC under one coordinated operating model, with consistent governance and communication.
• Benefit from transparent delivery and predictable timelines to support board, partner, and investor discussions.

Meet Our Team:

• Dr. Judith Ng-Cashin — Chief Medical Officer
• Barry Murphy — Chief Commercial Officer
• Dr. Yooni Kim — Chief Product Officer
• Michael Stibilj — Chief Operating Officer
• Rick Farris — Managing Director, North America
• Andy Liu — Managing Director, China
• David Ng — VP, Biometrics

Plus commercial and clinical teams from North America, Europe, and APAC.